Recognized by the premium investment forum – Animal Health Investment Europe 2020 – LiVET has been selected among 20 top animal health startups to present their rapid on-site diagnostic solution in front of the industry’s most influential figures and investors.

LiVET is a Swiss startup with a profound knowledge and expertise in molecular detection of microorganisms. Their rapid molecular point-of-care diagnostic tests provide early and correct diagnosis of infectious diseases in animals. Lab-quality results are guaranteed within 30 min, for up to 16 samples at once, which allows for immediate and specific treatment. By bringing the application of specialized laboratories closer to the patients they strive to increase the quality of animal health care. Working closely with LiVET our team at Hemex supported them in further developing their marketing efforts as well as to improve their odds in fundraising process by building a compelling visual presentation for their London pitch.

Tim Pfister of LiVET presenting among 20 top animal health startups at Animal Health Investment Europe 2020 Tim Pfister of LiVET presenting among 20 top animal health startups at Animal Health Investment Europe 2020As the animal health industry experiences a shift towards the detection and prevention of disease rather than simply the treatment of it, the Animal Health Investment Europe 2020 forum focuses on presenting innovation in nutritional health, data analytics, sensors and diagnostics. While showcasing the most exciting investment opportunities in animal health and nutrition the forum is also connecting those businesses with financial investors and strategic corporate partners. Bringing together academics, investors, startups and industry leaders animal health and nutrition companies are given a great opportunity to learn from and adapt to the impacts of disruptive technologies as well as possibility to meet face-to-face with decision makers from the full spectrum of the animal pharma and nutritional health industry.